So far, so good for lung cancer SBRT.

Abstract

In this issue of the Journal of Thoracic Oncology, Stephans et al. from the Cleveland Clinic report their review of pulmonary function testing (PFT) before and after stereotactic body radiation therapy (SBRT) for stage I lung cancer.1 Though retrospective, this contribution is meaningful. The “believers” know that SBRT offers a substantial improvement in… (More)
DOI: 10.1097/JTO.0b013e3181a99bda

Topics

  • Presentations referencing similar topics